Skip to content
Screener

CapEx at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$1.2B-509%
Danaher logo
DanaherDHR
$269M+8.5%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$4.44M-1.4%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$30M-12.8%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$31.11M-11.9%
TEC
Bio-TechneTECH
$9.09M-10.2%

Other financials

Income statement

See full
Revenue$204.1M+11.9%
Gross profit$110.0M+20.7%
Operating income$14.0M+0.6%
Net income$5.0M-66.3%
EPS (diluted)$0.09-65.4%

Balance sheet

See full
Cash & equivalents$606.8M-14.4%
Total debt$690.9M+354%
Total equity$2.1B+2.4%
Total assets$3.0B+1.7%

Cash flow

See full
Operating cash flow$32.8M+14.5%
Free cash flow$27.4M+27.5%

Valuation

See full
Market cap$8.95B+42.1%
Enterprise value$9.03B+57.3%
P/E215.5×
P/S11.6×+0.3×

Profitability

See full
Gross margin47.6%+0.9pp
Operating margin15.6%-11.0pp
Net margin17.3%-3.5pp
FCF margin22%+6.9pp

Returns & leverage

See full
Return on equity2%+1.6pp
Debt / equity0.3×+0.3×
Current ratio9.1×+0.5×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Repligen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323773
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Purchases of marketable securities(130,698)
Maturities of marketable securities132,000
Additions to capitalized software costs(972)(1,371)
Purchases of property, plant and equipment(10,044)(10,664)
Sale of property, plant and equipment42
Total cash used in investing activities(6,077)(81,947)
Cash flows for financing activities
Proceeds from exercise of stock options941,464

ITEM 1. Financial Statements

FAQ

What is Repligen's capex?
Repligen (RGEN) reported capex of $5.33M in Q2 2026.
How has Repligen's capex changed year-over-year?
Repligen's capex decreased by 24.9% year-over-year, from $7.1M to $5.33M.
What is the long-term trend for Repligen's capex?
Over 4 years (2021 to 2025), Repligen's capex has grown at a -23.1% compound annual growth rate (CAGR), from $67.09M to $23.52M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ask your AI about Repligen's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude